(Q46508770)

English

A randomized, double-blind, double-dummy, safety crossover trial comparing cumulative doses up to 96 microg of formoterol delivered via an HFA-134a-propelled pMDI vs. same cumulative doses of formoterol DPI and placebo in asthmatic patients

scientific article published in January 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15915010

A randomized, double-blind, double-dummy, safety crossover trial comparing cumulative doses up to 96 microg of formoterol delivered via an HFA-134a-propelled pMDI vs. same cumulative doses of formoterol DPI and placebo in asthmatic patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15915010

0 references

1 reference

based on heuristic

inferred from title

author name string

M Molimard

1

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15915010

E Guenolé

2

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15915010

T Duvauchelle

3

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15915010

E Vicaut

4

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15915010

G Lefrançois

5

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15915010

publication date

1 January 2005

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15915010

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15915010

72 Suppl 1

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15915010

28-34

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15915010

Budesonide Modulite: improving the changeover to CFC-free treatments

1 reference

https://api.crossref.org/works/10.1159%2F000083690

21 January 2018

Modulite technology: pharmacodynamic and pharmacokinetic implications

1 reference

https://api.crossref.org/works/10.1159%2F000083690

21 January 2018

Equivalent asthma control and systemic safety of inhaled budesonide delivered via HFA-134a or CFC propellant in a broad range of doses

1 reference

https://api.crossref.org/works/10.1159%2F000083690

21 January 2018

The formulation and evaluation of a CFC-free budesonide pressurised metered dose inhaler

1 reference

https://api.crossref.org/works/10.1159%2F000083690

21 January 2018

Efficacy and safety of inhaled budesonide delivered once or twice daily via HFA-134a in mild to moderate persistent asthma in adult patients. Comparison with budesonide CFC.

1 reference

https://api.crossref.org/works/10.1159%2F000083690

21 January 2018

Safety of formoterol by Turbuhaler as reliever medication compared with terbutaline in moderate asthma

1 reference

https://api.crossref.org/works/10.1159%2F000083690

21 January 2018

Adverse effects of beta-agonists: are they clinically relevant?

1 reference

https://api.crossref.org/works/10.1159%2F000083690

21 January 2018

Identifiers

10.1159/000083690

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15915010

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15915010

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46508770&oldid=2115324300"